F5 INC SEC Filings

Form 144 notice reports a proposed sale of 1,300 common shares by Francois Locoh-Donou through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $416,793.00. The issuer’s outstanding shares are listed as 57,447,170. The shares to be sold were originally acquired as restricted stock: 252 shares on 05/01/2021 and 1,048 shares on 02/01/2021. The filing also discloses two recent sales by the same person in the past three months: 1,300 shares on 09/02/2025 for $402,493.00 and 1,300 shares on 08/01/2025 for $400,582.00. The notice includes the required certification that the seller is not aware of undisclosed material adverse information.

F5, Inc. (FFIV) Form 4 summary — The reporting person, Schramm Lyra Amber, identified as Chief People Officer, reported a sale of 2,701 shares of F5 common stock on 09/08/2025 at a price of $316.57 per share. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025. Following the reported disposition the filing shows 0 shares beneficially owned. The Form 4 was signed by Angelique M. Okeke by power of attorney on 09/09/2025. This disclosure records an officer-initiated sale under a pre-established plan; no additional financial results, forward guidance, or other transactions are included in this filing.

Form 144 filed for F5, Inc. (FFIV) shows a proposed sale of 2,701 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $855,055.57. The filing lists three tranches of restricted stock acquired from the issuer on 02/01/2025 (200 shares), 05/01/2025 (2,291 shares), and 08/01/2025 (210 shares), all paid on their acquisition dates. No securities were reported sold in the prior three months. The filer certifies they are not aware of undisclosed material adverse information. The notice documents the intent to sell shares by an individual for whose account the securities were issued and identifies the executing broker and approximate sale date of 09/08/2025.

Locoh-Donou Francois, President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of common stock on 09/02/2025 at a price of $309.61 per share. After the sale, he beneficially owned 108,853 shares directly and 42,000 shares indirectly through a family trust. The Form 4 indicates the sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024. The filing was signed by an authorized representative by power of attorney on 09/04/2025.

Form 144 notice indicates proposed sale of 1,300 common shares by an officer/person for whose account the securities are to be sold, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $402,493.00. The filing shows the 1,300 shares were acquired as restricted stock on 02/01/2021 (589 shares) and 11/01/2022 (711 shares). The issuer’s outstanding shares are listed as 57,447,170. The filing also discloses two prior common-stock sales by the same person: 1,300 shares on 08/01/2025 for $400,582.00 and 1,300 shares on 07/01/2025 for $382,616.00. The signer represents they are not aware of undisclosed material adverse information and includes the standard criminal-misstatement warning.

Chad Michael Whalen, EVP Worldwide Sales of F5, Inc. (FFIV), reported multiple open-market sales executed under a Rule 10b5-1 trading plan dated April 30, 2025. The filing shows four sales on 08/11/2025 totaling 5,297 shares, with weighted-average sale prices running from $320.24 to $323.07 per share.

Those entries in Table I show the reporting person’s direct beneficial ownership declining across the transactions to a reported holding of 23,591 shares following the sales. The filing notes the transactions were made pursuant to the pre-established 10b5-1 plan and provides weighted-price ranges for transparency.

F5, Inc. filed a Form 144 notice indicating a proposed sale of 5,297 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $1,706,874.03 and shows 57,447,170 shares outstanding, indicating the proposed sale is a small portion of the company's total shares.

The shares were acquired as restricted stock from the issuer on 08/01/2018 and payment is recorded as on that date. The filer reports no securities sold in the past three months and makes the standard representation that they do not possess undisclosed material information; the filing references Rule 10b5-1 language but does not provide a plan adoption date.